Fatal Chemotherapy Side Effects

Chemotherapy can cure cancer in some patients. It can extend life in others. And, in some patients, it can be fatal.

Such is the paradox of chemotherapy treatment. Chemotherapy was developed with a very broad solution in mind: what chemicals kill cancer cells but can be tolerated by humans? Researchers tested thousands of chemicals in the 1950s and 1960s, looking for a chemical that would kill cells in the human body, but not too many cells.

After all, chemotherapy has no idea if it is killing healthy cells or cancer cells. It is an indiscriminate treatment. Consequently, it can kill or negatively affect healthy cells and sometimes lead to fatal events. A handful of them are listed below.

Secondary Cancer

Chemotherapy can cure one cancer and cause the development of a new cancer, which may or may not prove fatal.

Tumor lysis syndrome

Tumor lysis syndrome is a metabolic crisis that occurs when cancer cells die in large quantities, sometimes as a result of chemotherapy (this is generally more true for solid tumor cancers than blood cancers) or other cytotoxic measures. The kidneys become overwhelmed and can fail.

One known potential side effect of the monoclonal antibody Rituxan is tumor lysis syndrome.

Cardiotoxicity

There are some chemotherapy drugs that can sufficiently damage the heart so as to lead to a fatal event. Generally, these drugs fall under the category of anthracyclines. A commonly used anthracycline in lymphoma treatments is doxorubicin.

Febrile neutropenia

Some chemotherapy treatments can deplete patients of healthy B-lymphocytes. As a consequence, they become vulnerable to infections that their body cannot fight off. This is more true in older patients than younger ones. One sign of such an infection is a high fever, known in this instance as febrile neutropenia.

Allergic reaction

There is always a chance that a patient may be allergic to a certain chemotherapy drug and will suffer an allergic reaction upon receiving it. Such a reaction can often be mitigated by medical personnel since patients receive chemotherapy under the supervision of medical professionals.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap